giantsight

© giantsight

What's NewFAQTermsPrivacy
13F Filing

BAKER BROS. ADVISORS LP

Period2025.10.01 ~ 2025.12.31
Filed2026.02.17
Filing
Current Portfolio
$17.08B
Reported total portfolio value per 13F filing
Previous Portfolio
$13.84B
Change
+23.41%

Holdings

Scroll
#Company% of PortfolioActivity
Market Value
SharesChangeSector
1
Incyte Corporation
INCY
Incyte Corporation
17.78%
Increased
$3.04B
30,743,991
+328
Healthcare
2
BeOne Medicines Ltd.
ONC
BeOne Medicines Ltd.
15.65%
$2.67B
8,799,053
-
Health Technology
3
Madrigal Pharmaceuticals, Inc.
MDGL
Madrigal Pharmaceuticals, Inc.
7.30%
$1.25B
2,141,701
-
Health technology
4
Insmed Incorporated
INSM
Insmed Incorporated
6.72%
Reduced
$1.15B
6,592,746
-110,738
Health technology
5
ACADIA Pharmaceuticals Inc.
ACAD
ACADIA Pharmaceuticals Inc.
6.71%
$1.15B
42,896,690
-
Health technology
6
Celcuity Inc.
CELC
Celcuity Inc.
4.62%
$790M
7,915,792
-
Health technology
7
Revolution Medicines, Inc.
RVMD
Revolution Medicines, Inc.
4.41%
$753M
9,455,357
-
Health technology
8
Kymera Therapeutics, Inc.
KYMR
Kymera Therapeutics, Inc.
3.94%
Increased
$674M
8,657,242
+2,005,813
Health technology
9
Summit Therapeutics Inc.
SMMT
Summit Therapeutics Inc.
3.73%
Increased
$636M
36,391,063
+2,668,089
Health technology
10
Rhythm Pharmaceuticals, Inc.
RYTM
Rhythm Pharmaceuticals, Inc.
3.51%
$600M
5,604,483
-
Health technology

Portfolio Changes

Buy Positions

New Buy

  • Terns Pharmaceuticals, Inc.
    TERNTerns Pharmaceuticals, Inc.

    Current 0.22%

    +950,000Shares

  • Jade Biosciences, Inc.
    Jade Biosciences, Inc.

    Current 0.15%

    +1,641,137Shares

  • BioCryst Pharmaceuticals, Inc.
    BCRXBioCryst Pharmaceuticals, Inc.

    Current 0.13%

    +2,822,727Shares

  • Centessa Pharmaceuticals plc
    CNTACentessa Pharmaceuticals plc

    Current 0.10%

    +670,751Shares

  • Dyne Therapeutics, Inc.
    DYNDyne Therapeutics, Inc.

    Current 0.09%

    +813,449Shares

Additional Buy

  • Incyte Corporation
    INCYIncyte Corporation

    <0.01%

    +328Shares

  • Kymera Therapeutics, Inc.
    KYMRKymera Therapeutics, Inc.

    +30.16%

    +2,005,813Shares

  • Summit Therapeutics Inc.
    SMMTSummit Therapeutics Inc.

    +7.91%

    +2,668,089Shares

  • Kodiak Sciences Inc.
    KODKodiak Sciences Inc.

    +15.07%

    +2,608,696Shares

  • Praxis Precision Medicines, Inc.
    PRAXPraxis Precision Medicines, Inc.

    +63.38%

    +437,000Shares

Sell Positions

Full Exit

  • Vaxcyte, Inc.
    PCVXVaxcyte, Inc.

    Full Exit

    0Shares

  • Agios Pharmaceuticals, Inc.
    AGIOAgios Pharmaceuticals, Inc.

    Full Exit

    0Shares

  • Avidity Biosciences, Inc.
    RNAAvidity Biosciences, Inc.

    Full Exit

    0Shares

  • Intellia Therapeutics, Inc.
    NTLAIntellia Therapeutics, Inc.

    Full Exit

    0Shares

  • Opthea Limited
    OPTOpthea Limited

    Full Exit

    0Shares

Partial Exit

  • Insmed Incorporated
    INSMInsmed Incorporated

    -1.65%

    -110,738Shares

  • Edgewise Therapeutics, Inc.
    EWTXEdgewise Therapeutics, Inc.

    -9.99%

    -730,000Shares

  • Stoke Therapeutics, Inc.
    STOKStoke Therapeutics, Inc.

    -27.99%

    -1,297,141Shares

  • Structure Therapeutics Inc.
    GPCRStructure Therapeutics Inc.

    -7.94%

    -123,580Shares

  • Monte Rosa Therapeutics, Inc.
    GLUEMonte Rosa Therapeutics, Inc.

    -11.60%

    -570,359Shares